Dianthus Therapeutics (DNTH) PT Raised to $120 at Stifel

March 9, 2026 10:14 AM

Stifel analyst Alex Thompson raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $120.00 (from $65.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found